GSK sells legacy meningitis vaccines to Pfizer amid Novartis influx
This article was originally published in Scrip
Executive Summary
GlaxoSmithKline is divesting its older meningitis vaccines Nimenrix and Mencevax to Pfizer Ireland Pharmaceuticals (a subsidiary of Pfizer) for €115m.